Bajaj Healthcare Ltd.
Snapshot View

View in App

Prices View details >>

388.05 +5.30 ▲1.4%

16 August 2022, 03:53:21 PM
Volume: 107,083

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.bajajhealth.com
Market Cap 1,029.14 Cr.
Enterprise Value(EV) 1,316.65 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 23.26 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 16.03 Trailing Twelve Months Ending 2022-06
Industry PE 32.02 Trailing Twelve Months Ending 2022-06
Book Value / Share 123.38 Trailing Twelve Months Ending 2022-06
Price to Book Value 3.02 Calculated using Price: 372.90
Dividend Yield 0.40 Period Ending 2021-03
No. of Shares Subscribed 2.76 Cr. 27,598,400 Shares
FaceValue 5
Company Profile
Bajaj Healthcare is a pharmaceutical company with manufacturing and marketing capabilities in Active Pharmaceutical Ingredients (APIs), Intermediates and Finished Dosage Formulations (FDFs) with focus on Vitamins, Amino Acids, Anti-Convulsants and Finished Dosage Forms (FDFs) caters to various therapeutic segments.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+1.38%
1 Week
+0.38%
1 Month
+10.65%
3 Month
+26.96%
6 Month
+0.51%
1 Year
2 Year
5 Year
10 Year

Ratios View Details >>

9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) -3.74 7.31 22.38 19.60 10.77 17.68 20.18 18.92 38.09
Return on Capital Employed (%) 5.11 10.67 19.16 18.00 14.52 18.25 19.75 19.47 35.91
Return on Assets (%) -0.84 1.53 4.50 4.12 3.65 6.23 6.10 8.28 19.14

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 29 31 82 89 99 114 129 178 258 328
Non Curr. Liab. 16 14 22 32 28 23 20 27 85 71
Curr. Liab. 85 99 85 88 93 131 117 138 183 322
Minority Int.
Equity & Liab. 130 145 189 209 219 268 267 343 526 721
Non Curr. Assets 59 59 110 131 128 129 130 175 267 323
Curr. Assets 71 86 79 78 91 140 137 168 258 398
Misc. Exp. not W/O
Total Assets 130 145 189 209 219 268 267 343 526 721

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 157 186 197 200 207 290 325 410 657 666
Other Income 0 0 0 0 2 2 1 7 7 1
Total Income 157 186 197 201 210 292 326 417 664 668
Total Expenditure -144 -166 -168 -170 -176 -250 -282 -362 -521 -555
PBIDT 13 20 29 30 33 42 44 55 143 112
Interest -6 -7 -8 -8 -8 -8 -8 -7 -8 -14
Depreciation -8 -9 -9 -9 -11 -11 -11 -12 -16 -20
Taxation 0 -1 -5 -5 -6 -8 -8 -11 -36 -14
Exceptional Items
PAT -1 2 8 8 8 15 16 25 83 64
Adjusted EPS 0 1 3 3 3 6 6 9 30 23

Cash Flow View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 9 15 17 28 25 22 17 25 21 44
Cash Fr. Inv. -15 -8 -9 -17 -31 -8 -12 -13 -28 -109
Cash Fr. Finan. 6 -7 -8 -11 5 -13 2 -13 3 75
Net Change 0 0 1 0 0 0 7 0 -4 10
Cash & Cash Eqvt 1 0 1 1 0 1 8 8 4 14

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 67.26 67.26 67.26 67.26 67.26 67.26 67.26 67.26 67.30
Public 32.74 32.74 32.74 32.74 32.74 32.74 32.74 32.74 32.70
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 12 Aug 2022
Outcome of Board Meeting
Bajaj Healthcare Limited has informed the Exchange about Board Meeting held on 12-Aug-2022 to consider financial statements for the period ended June 2022 and Other business matters
Fri, 29 Jul 2022
Price movement
BAJAJHCARE : Significant movement in price has been observed in Bajaj Healthcare Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Bajaj Healthcare Limited has submitted their response.
Fri, 29 Jul 2022
Price movement
BAJAJHCARE : Significant movement in price has been observed in Bajaj Healthcare Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Bajaj Healthcare Limited has submitted their response.

Technical Scans View Details >>

Fri, 12 Aug 2022
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
Closing Below Previous Low Closing Below Previous Low

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,167.25 914.60 +0.1%
Divi's Laboratories Ltd. 98,918.90 3,732.00 +0.2%
Cipla Ltd. 82,906.37 1,034.55 +0.7%
Dr. Reddy's Laboratories Ltd. 70,920.35 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. 62,010.73 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. 51,917.53 1,573.70 +2.2%
Piramal Enterprises Ltd. 45,855.65 1,926.70 +0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.35 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 33.43 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-06 33.32 1,034.55 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.69 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 70.15 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 64.82 1,573.70 +2.2%
Piramal Enterprises Ltd. Consolidated 2022-06 24.38 1,926.70 +0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.37 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8.44 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-06 3.86 1,034.55 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.50 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.43 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.12 1,573.70 +2.2%
Piramal Enterprises Ltd. Consolidated 2022-06 1.28 1,926.70 +0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,034.55 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,573.70 +2.2%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,926.70 +0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,034.55 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,573.70 +2.2%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,926.70 +0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,034.55 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,573.70 +2.2%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,926.70 +0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,034.55 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,573.70 +2.2%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,926.70 +0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 914.60 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,732.00 +0.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,034.55 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,297.80 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,349.40 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,573.70 +2.2%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,926.70 +0.3%

FAQ's On Bajaj Healthcare Ltd.

Can I Buy Bajaj Healthcare Shares now?
What is the Share Price of Bajaj Healthcare?
What is the Relative Strength Index (RSI) Value of Bajaj Healthcare?
What is the Market Capital (MCAP) of Bajaj Healthcare?
What are the key metrics to analyse Bajaj Healthcare?
What is the Price Performance of Bajaj Healthcare?